Magnet Biomedicine
3 known investors
Magnet Biomedicine develops TrueGlue™, a molecular glue discovery platform for designing small molecule therapeutics that induce novel protein-protein interactions to treat cancer and immune disorders. The platform systematically identifies molecular glues capable of targeting historically difficult-to-drug proteins in precision medicine.
Founders & leadership
BF
Benjamin F. Cravatt, PhDFounder & Advisor
DA
David A. Spiegel, MD, PhDFounder & Advisor
MR
Michael Rosbash, PhDFounder & Advisor
RS
Richa Saxena, PhDFounder & Advisor
SS
Stuart Schreiber, PhDFounder & Advisor
Investors · 3
In the news
- Magnet Biomedicine: $50 Million Raised To Advance Molecular Glue Discoverypulse2.com · 2023
- Magnet Biomedicine Raises $50M in Funding | citybizcitybiz.co · 2023